BHM® COVID-19 IVD PRODUCTS RECEIVES CE MARKING
Birmingham Biotech has registered the BHM® COVID-19 Antigen Sealing Tube Test Strip, a lateral flow immunochromatographic assay for in vitro qualitative detection of COVID-19 nucleocapsid protein antigen. The test strip is in a sealing tube to avoid potential biosecurity substances from a clinical sample, which will much help to avoid pathogen contamination and spreading to the operator and its environment.
Birmingham Biotech has registered the BHM® COVID-19 Antigen Rapid Test, a lateral flow immunochromatographic assay for in vitro qualitative detection of COVID-19 nucleocapsid protein antigen. The reagent utilises the principle of double antibody sandwich combines with colloidal gold immunochromatography.
Birmingham Biotech has registered the BHM® SARS-CoV-2-NP Ab Rapid Test. The reagent employs lateral flow immunofluorescent double-antigen sandwich assay in a cassette format with Immunofluorescence Analyser. The product is used for in vitro qualitative detection of anti-SARS-CoV-2-NP antibody (total antibody against SARS-CoV-2 nucleocapsid protein) in human serum.
Birmingham Biotech has registered the BHM® SARS-CoV-2-S1 Ab Rapid Test. The reagent employs lateral flow immunofluorescent double-antigen sandwich assay in a cassette format with Immunofluorescence Analyser. The product is used for in vitro qualitative detection of anti-SARS-CoV-2-S1 antibody (total antibody against SARS-CoV-2 spike 1 protein) in human serum.
Birmingham Biotech has registered the BHM® SARS-CoV-2 Ab Detection ELISA Kit. The kit is used for in vitro qualitative detection of antibodies to the COVID-19 N protein in human serum. The kit uses the double antigen sandwich method. The kit contains the gene-expressing novel coronavirus N protein-coated microplate.
Birmingham Biotech has registered the BHM® SARS-CoV-2-S1 Ab Detection ELISA Kit. The kit is used for in vitro qualitative detection of antibodies to the COVID-19 S protein in human serum. The kit uses the double antigen sandwich method. The kit contains the gene-expressing novel coronavirus S protein-coated microplate.
Birmingham Biotech has registered the BHM® 2019-nCoV Nucleic Acid Test Kit (PCR-fluorescent probe method, lyophilized). This kit is a real-time reverse transcription polymerase chain reaction (rRT -PCR) test specially targeting at ORF1ab and N genes of SARS-CoV-2.
Birmingham Biotech has registered the BHM® Virus Nucleic Acid Extraction Kit or Nucleic Acid Detection Kit. This kit is used to extract virus DNA/RNA from plasma, serum, ascites, cell culture supernatant, cerebrospinal fluid, stool, tissue and other samples. The extracted nucleic acid can be used for clinical molecular biology detection